No Data
Jilin Aodong Pharmaceutical Group (000623.SZ): has cumulatively repurchased 1.36% of shares.
On January 2nd, Gelonghui reported that Jilin Aodong Pharmaceutical Group (000623.SZ) announced that as of December 31, 2024, the company had cumulatively repurchased 16,251,900 shares through its dedicated securities account for share repurchase via centralized bidding, accounting for 1.36% of the company's total share capital of 1,195,895,387 shares as of December 31, 2024, with a maximum Fill Price of 19.21 yuan/share, a minimum Fill Price of 17.70 yuan/share, and a total payment amount of approximately 0.3 billion yuan (excluding transaction costs).
Health Check: How Prudently Does Jilin Aodong Pharmaceutical Group (SZSE:000623) Use Debt?
Jilin Aodong Pharmaceutical Group (000623.SZ): Taonan Pharmaceutical has obtained the pharmaceutical registration certificate for granules.
Gelonghui November 27th | Jilin Aodong (000623.SZ) announced that recently, Jilin Aodong Pharmaceutical Group Co., Ltd., a holding subsidiary of Jilin Aodong Pharmaceutical Group, received the 《Drug Registration Certificate》 of Guanyan Decoction Granules issued by the National Medical Products Administration. The main functions of Guanyan Decoction Granules are nourishing yin and soothing the liver. It is used for liver yin deficiency, blood dryness and qi stagnation syndrome. Symptoms include chest and hypochondriac pain, acid regurgitation, bitter taste in the mouth, dry throat, red and less fluid tongue, and thin and stringy pulse. It is also used to treat hernia and accumulation.
Aodong Pharmaceutical Gets Agricultural Bank of China's Assurance to Receive the 420 Million Yuan Loan
jilin aodong pharmaceutical group (000623.SZ): plans to invest 0.3 to -0.6 billion yuan to repurchase shares
Ge Longhui, November 8th | Jilin Aodong Pharmaceutical Group (000623.SZ) announced that the company plans to repurchase the RMB common stocks (A shares) issued by the company. The total amount of funds to be used for this repurchase is not less than RMB 0.3 billion (inclusive) and not more than RMB 0.6 billion (inclusive). Based on the calculation of the repurchase price ceiling, the maximum number of shares to be repurchased this time is 24 million shares, which is no more than 2.01% of the total share capital of 1,195,895,387 shares of the company as of September 30, 2024; the minimum is 12 million shares, which is not less than the total share capital of the company as of September 30, 2024
jilin aodong pharmaceutical group (000623.SZ): The mid-year cash dividend in 2024 is 2 yuan per 10 shares, with the equity registration date on November 7th.
On October 31, Gelonhui reported that jilin aodong pharmaceutical group (000623.SZ) announced that the company's mid-term cash dividend plan for 2024: based on the current total share capital of 1,195,895,387 shares, the company will distribute 2.00 RMB cash per 10 shares to all shareholders (including tax). The record date for equity registration is November 7, 2024, and the ex-dividend date is November 8, 2024.
No Data
